Becker's Healthcare December 23, 2024
Paige Twenter

Nearly three years after its launch, Mark Cuban Cost Plus Drug Co. now manufactures injectables in shortage, works with thousands of healthcare facilities, including pharmacies, hospitals, long-term care sites and clinics, and offers more than 2,000 discounted generics and about a dozen branded medicines.

In an email Q&A with Becker’s, Mark Cuban said his pharmaceutical company’s central theme in 2024 has been exponential growth.

“But beyond that,” Mr. Cuban said, “Not much :).”

Cost Plus Drugs’ CEO and co-founder, Alex Oshmyansky, MD, PhD, told Becker’s in June that the company directly works with 38 of the 40 largest generic manufacturers and multiple secondary distributors. These relationships have helped Cost Plus Drugs supply cheaper medications for hundreds of medical...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
Building Resilience: CDMO Strategies for Drug Supply Chain Stability
STAT+: How Trump’s tariffs may raise health care costs, from medical devices to prescription drugs
ASHP to CMS: 'Change course' on drug pricing
Many independent pharmacists will not stock drugs in the price negotiation program
Measuring Progress for Life Sciences: Trust, Patient Access, and Prevention at a Fork in the Road of Public Health

Share This Article